Insulet PODD Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $302.8M-24.7% | $247.1M-40.9% | $246.2M-41.5% | $236.1M-40.3% | $402.2M+71.9% | ||
| $94.9M+13.4% | $90.4M+11.9% | $87.5M+12.0% | $86.8M+15.0% | $83.7M+12.5% | ||
| $65.8M-10.2% | $62.7M-9.5% | $62.4M+0.6% | $63.8M+17.3% | $73.3M+45.1% | ||
| $66.2M— | $62.2M— | —— | —— | —— | ||
| $4.4M-43.6% | $6.2M-15.1% | $7.3M-2.7% | $8.1M+8.0% | $7.8M+8.3% | ||
| —— | —— | $4.3M+438% | $4.2M+367% | $3.2M+39.1% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $61.3M+78.7% | $81.7M+273% | $60.6M+76.2% | $37.8M-0.5% | $34.3M+51.1% | ||
| $2.8M-67.4% | $7M+42.9% | $5M-24.2% | $4.3M— | $8.6M— | ||
| -$84.4M-114% | -$123.9M— | -$123.9M— | -$123.9M— | -$39.5M— | ||
| $619.3M+52.4% | $569.3M+32.3% | $533.5M+62.7% | $516.1M+87.3% | $406.4M+74.6% | ||
| $203.6M+76.9% | $191.6M+53.4% | $110.1M+9.4% | $111.2M+18.3% | $115.1M+32.0% | ||
| —— | $3.2M— | $2.4M+220% | $1.6M+6.7% | $800K-64.4% | ||
| -$234.8M-70.4% | -$222.7M-52.3% | -$137.9M-25.6% | -$136.2M-32.1% | -$137.8M-36.0% | ||
| $359.6M— | $59.6M— | $59.6M— | $30.1M— | —— | ||
| —— | —— | —— | —— | $440.7M— | ||
| $888.3M+442% | $1.05B— | $1.05B— | $541.5M— | $163.9M— | ||
| $16.9M+245% | $19M+132% | $17.7M+52.6% | $13.9M+27.5% | $4.9M-69.6% | ||
| $20.4M-14.3% | $25.9M+241% | $25.7M+262% | $24.4M+281% | $23.8M+250% | ||
| -$1.19B— | -$595.3M— | -$543.6M— | -$88.5M— | —— | ||
| —— | —— | —— | $9.3M+681% | -$500K+16.7% | ||
| -$802.7M-251% | -$237.3M-195% | -$145.2M-167% | $300.6M— | $531.9M— | ||
| $4.4M-43.6% | $6.2M-15.1% | $7.3M-2.7% | $8.1M+8.0% | $7.8M+8.3% | ||
| —— | —— | —— | —— | —— | ||
| $61.3M+78.7% | $81.7M+273% | $60.6M+76.2% | $37.8M-0.5% | $34.3M+51.1% | ||
| —— | —— | $4.3M+438% | $4.2M+367% | $3.2M+39.1% | ||
| —— | $5.4M+2,800% | $4M+841% | $2.6M+148% | $1.2M-28.4% | ||
| —— | $3.2M— | $2.4M+220% | $1.6M+6.7% | $800K-64.4% | ||
| $19.3M+82.1% | $19.2M+111% | $15.9M+76.7% | $12.8M+43.8% | $10.6M+19.1% | ||
| —— | —— | —— | —— | $440.7M— | ||
| $141.5M— | $164.6M— | $164.6M— | $75.7M— | —— | ||
| $888.3M+442% | $1.05B— | $1.05B— | $541.5M— | $163.9M— | ||
| $49M+1.7% | $62.4M+79.3% | $64.4M+274% | $59.2M— | $48.2M— | ||
| $34.5M-43.3% | $49.9M+9.7% | $62.3M+91.1% | $63.7M— | $60.9M— | ||
| $415.7M+42.7% | $377.7M+23.7% | $423.4M+86.3% | $404.9M+123% | $291.3M+100% | ||
| $415.7M+42.7% | $377.7M+23.7% | $423.4M+86.3% | $404.9M+123% | $291.3M+100% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Insulet generate?
- Insulet (PODD) generated $619.3M in operating cash flow over the trailing twelve months.
- What is Insulet's free cash flow?
- After $203.6M of capital expenditures, Insulet's free cash flow was $415.7M over the trailing twelve months, up 42.7% year over year.
- Where does Insulet's cash flow data come from?
- Every line is extracted from Insulet's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
